Ashcraft, K.; Grande, K.; Bristow, S.L.; Moyer, N.; Schmidlen, T.; Moretz, C.; Wick, J.A.; Blaxall, B.C.
Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population. J. Pers. Med. 2022, 12, 1972.
https://doi.org/10.3390/jpm12121972
AMA Style
Ashcraft K, Grande K, Bristow SL, Moyer N, Schmidlen T, Moretz C, Wick JA, Blaxall BC.
Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population. Journal of Personalized Medicine. 2022; 12(12):1972.
https://doi.org/10.3390/jpm12121972
Chicago/Turabian Style
Ashcraft, Kristine, Kendra Grande, Sara L. Bristow, Nicolas Moyer, Tara Schmidlen, Chad Moretz, Jennifer A. Wick, and Burns C. Blaxall.
2022. "Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population" Journal of Personalized Medicine 12, no. 12: 1972.
https://doi.org/10.3390/jpm12121972
APA Style
Ashcraft, K., Grande, K., Bristow, S. L., Moyer, N., Schmidlen, T., Moretz, C., Wick, J. A., & Blaxall, B. C.
(2022). Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population. Journal of Personalized Medicine, 12(12), 1972.
https://doi.org/10.3390/jpm12121972